ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Zura Bio Ltd
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.81−0.07 (-1.80%)
Close on Oct 19, 2026
- Market cap
- $483.12M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Zura Bio has not reported a dividend
No dividend per share appears in Zura Bio's annual filings since fiscal 2021.